Imuniti, a manufacturer and marketer of pharmaceutical products and complimentery natural medicines, has revealed the identity of its new black economic empowerment (BEE) partner as Pac-Con Research, a Durban-based packaging company, reported Business Report.
According to Neil Lamble, the acting chief executive at Imuniti, the company would outsource the production of subsidiary Impilo Drugs to its new BEE partner as part of its cost-saving and turnaround strategy.
In 2009, Imuniti also specified that it had found another BEE partner after it had called it quits with an empowerment consortium with strong political links because the targets agreed upon were not met.
The consortium was made up of Kopano Logistic Services, wholly owned by the investment arm of Cosatu; Malibongwe Women’s Development Trust, a non-profit organisation of the ANC Women’s League; Star Choice Trading, owned by Tembi Tambo, the daughter of Oliver and Adelaide Tambo; Tshehetsa Management Services and Mudjadji Trading
The consortium was forced to return shares to the founding shareholders of the company. Last year, Imuniti denied to reveal the identity of its new BEE partner, sayin that it was in the process of informing its key customers.
Some of the customers of Pac-Con Research include Reckitt Benckiser, Alliance Pharmaceuticals and Saralte. Reportedly it has working relationship with Chesham Chemicals in the UK and pharmaceutical companies in the US.